CyberAgent, Inc.
CyberAgent, Inc. (4751.T) Financial Performance & Income Statement Overview
Analyze CyberAgent, Inc. (4751.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
CyberAgent, Inc. (4751.T) Income Statement & Financial Overview
View the income breakdown for CyberAgent, Inc. 4751.T across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $217.37B | $203.84B | $204.41B | $190.38B |
| Cost of Revenue | $151.54B | $149.86B | $148.50B | $141.40B |
| Gross Profit | $65.83B | $53.98B | $55.91B | $48.98B |
| Gross Profit Ratio | $0.30 | $0.26 | $0.27 | $0.26 |
| R&D Expenses | $0.00 | $0.00 | $5.67B | $0.00 |
| SG&A Expenses | $44.96B | $45.68B | $50.002B | $40.45B |
| Operating Expenses | $44.96B | $45.68B | $50.002B | $40.45B |
| Total Costs & Expenses | $196.50B | $195.54B | $198.50B | $181.85B |
| Interest Income | $106.00M | $103.00M | $141.00M | $117.00M |
| Interest Expense | $90.00M | $0.00 | $74.00M | $60.00M |
| Depreciation & Amortization | $1.89B | $2.61B | $1.72B | $2.97B |
| EBITDA | $22.48B | $10.91B | $2.90B | $11.38B |
| EBITDA Ratio | $0.10 | $0.05 | $0.01 | $0.06 |
| Operating Income | $20.87B | $8.30B | $5.91B | $8.52B |
| Operating Income Ratio | $0.10 | $0.04 | $0.03 | $0.04 |
| Other Income/Expenses (Net) | -$369.00M | $902.00M | -$6.74B | $498.00M |
| Income Before Tax | $20.50B | $9.20B | -$827.00M | $9.02B |
| Income Before Tax Ratio | $0.09 | $0.05 | -$0.004 | $0.05 |
| Income Tax Expense | $6.56B | $3.21B | -$1.08B | $2.28B |
| Net Income | $10.79B | $5.07B | $421.00M | $5.96B |
| Net Income Ratio | $0.05 | $0.02 | $0.002 | $0.03 |
| EPS | $21.31 | $9.21 | $0.83 | $11.77 |
| Diluted EPS | $20.33 | $9.21 | $0.83 | $10.83 |
| Weighted Avg Shares Outstanding | $506.44M | $506.37M | $506.34M | $506.27M |
| Weighted Avg Shares Outstanding (Diluted) | $550.60M | $550.60M | $506.92M | $550.23M |
Financial performance has remained strong, with revenue growing from $190.38B in Q3 2024 to $217.37B in Q2 2025. Gross profit continued to perform well, with margins at 30% in the latest quarter. Operating income reached $20.87B in Q2 2025, holding a steady 10% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $22.48B. Net income rose to $10.79B, keeping EPS at $21.31. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan